WB-Based Exosome Verification
- Calnexin (endoplasmic reticulum marker)
- GM130 (Golgi apparatus marker)
- Histone H3 (nuclear protein marker)
- High-purity exosome isolation and enrichment services for multiple sample types, including blood, cell culture supernatants, and urine
- Multi-marker-based WB validation services
- Integrated downstream analytical solutions encompassing exosome proteomics, miRNA profiling, and lipidomics
Exosomes are small membrane-bound vesicles with diameters ranging from approximately 30 to 150 nm. They are secreted by diverse cell types via the endosomal-lysosomal pathway and are widely distributed in biological fluids, including blood, urine, saliva, and cerebrospinal fluid. In recent years, exosomes have attracted increasing attention due to their important roles in intercellular communication as well as their potential applications in disease diagnosis and therapeutic targeting. Given the substantial overlap in morphology and size between exosomes and other extracellular vesicles, such as microvesicles and apoptotic bodies, rigorous validation of isolated vesicles is essential to ensure the reliability of downstream analyses. As a classical method for protein-level validation, Western Blot (WB) plays a critical role in exosome characterization. By examining exosome-specific marker proteins, researchers can determine whether authentic exosomal components are effectively enriched in the sample.
Which Proteins Should Be Targeted for Exosome Marker Detection?
In WB-based exosome validation, the objective is not the detection of a single protein but rather the combined assessment of multiple positive and negative markers. Commonly used exosome-associated protein markers include the following:
1. Positive Markers
These proteins are broadly present in exosomes derived from most biological sources and include:
(1) CD9, CD63, CD81: Members of the tetraspanin family and well-established markers of exosomal membrane proteins
(2) TSG101: An endosome-associated protein and a key component of the ESCRT complex involved in exosome biogenesis
(3) Alix (PDCD6IP): Another ESCRT-related protein that is widely used for exosome validation
2. Negative Markers
These markers are used to exclude cellular contamination or the presence of non-exosomal components, such as:
The combined use of positive and negative markers is essential to confirm that the isolated vesicles represent pure exosomes rather than cellular debris or contamination from other organelles.
WB-Based Exosome Validation Workflow
Although Western Blot is a routine experimental technique, its application to exosome samples requires careful attention to several critical steps, including sample preparation, accurate protein quantification, and efficient membrane transfer.
Step 1: Exosome Isolation
Commonly used exosome isolation strategies include ultracentrifugation, commercial isolation kits, and size exclusion chromatography (SEC). These methods yield products with markedly different purity and concentration profiles. Therefore, it is recommended that particle size distribution and vesicle morphology be assessed (e.g., by NTA or electron microscopy) prior to WB analysis to ensure baseline sample quality.
Step 2: Protein Extraction and Quantification
(1) Because exosomes contain limited amounts of protein, highly efficient lysis buffers (such as RIPA) should be employed to achieve complete protein extraction. Protein concentration is preferably determined using the BCA assay to ensure consistent loading across lanes and to improve data comparability.
(2) Recommended protein loading: Approximately 20-30 μg of protein per lane is generally appropriate and may be adjusted based on antibody sensitivity.
Step 3: SDS-PAGE and Electrotransfer
(1) A resolving gel concentration of 12-15% is recommended to enhance the resolution of low-molecular-weight proteins (e.g., CD9 at ~24 kDa). Given the abundance of low-molecular-weight proteins in exosome samples, transfer conditions and membrane selection should be optimized accordingly.
(2) Transfer conditions: PVDF membranes are recommended, with wet transfer for approximately 1 hour or semi-dry transfer for about 45 minutes, to ensure efficient transfer of small proteins.
Step 4: Antibody Incubation and Detection
(1) The choice of primary antibodies is critical, and high-affinity antibodies validated for exosome-related applications are preferred.
(2) Typical primary antibody dilutions range from 1:1000 to 1:2000.
(3) HRP-conjugated secondary antibodies should be used in combination with ECL-based chemiluminescence for signal detection.
Note: CD63 frequently appears as multiple bands, which is a normal phenomenon resulting from differential glycosylation. For TSG101 detection, freshly prepared antibodies are recommended to avoid weak signals or elevated background.
Practical Strategies to Improve WB Validation Efficiency
To obtain high-quality and reproducible WB validation results, the following considerations are recommended:
1. Multi-Marker Validation
A single marker protein is insufficient to definitively characterize exosomes. At least two positive markers in combination with one negative marker should be included.
2. Inclusion of Parental Cell Lysate Controls
Incorporating parental cell lysates into WB analyses enables direct comparison of target protein expression between exosomes and source cells, thereby providing additional evidence of exosome enrichment.
3. Integration With Complementary Validation Methods
While WB provides information on protein expression, it does not reveal vesicle morphology or size distribution. Therefore, WB analysis should be complemented with transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA) for comprehensive validation.
MtoZ Biolabs: Enabling High-Quality Exosome Research
As exosome research continues to expand, experimental reproducibility and sample quality have become central concerns in the field. Leveraging its established proteomics and exosome omics platforms, MtoZ Biolabs provides:
Western Blot validation represents a fundamental step in exosome research. Appropriate marker selection, optimized protein processing workflows, and integration with complementary analytical techniques can substantially enhance data reliability and publication quality. In an increasingly competitive research environment, standardized technical platforms and specialized services play a critical role in enabling meaningful scientific advances. MtoZ Biolabs remains committed to providing efficient, advanced, and comprehensive exosome research solutions to support life science investigators worldwide.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
